Literature DB >> 12067687

Cancer causation: the Darwinian downside of past success?

Mel Greaves1.   

Abstract

Causal mechanisms in all diseases are diverse and multifactorial, but medical scientists, as pragmatists, inevitably focus on limited or circumscribed components of pathogenetic puzzles. In cancer, epidemiologists have traditionally sought to incriminate exposures; geneticists uncover inherited susceptibility; and molecular biologists deconstruct the proximal mechanisms of cell transformation. Molecular epidemiology promises to deliver new insights in terms of gene-environment interactions. Each of these endeavours has undeniably provided rich dividends and insights into cancer causation, but are these likely to be sufficient as a coherent explanation of our vulnerability to cancer? I suggest that the biological plausibility of causal mechanisms would benefit from a historical, evolutionary perspective. The essential argument is that genes or gene variants and phenotypic traits that were adaptively selected in the past as advantageous now contribute crucially to cancer because of their mismatch with current environmental and social circumstances. The risk attributes of skin pigmentation and some dietary factors in cancer can be plausibly interpreted within this context. A case is made here for a Darwinian perspective on breast and prostate cancers, for which current understanding of causation is limited and contentious.

Entities:  

Mesh:

Year:  2002        PMID: 12067687     DOI: 10.1016/s1470-2045(02)00716-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  18 in total

1.  Why disease persists: an evolutionary nosology.

Authors:  Robert L Perlman
Journal:  Med Health Care Philos       Date:  2005

2.  Population genetics of cancer cell clones: possible implications of cancer stem cells.

Authors:  Christopher T Naugler
Journal:  Theor Biol Med Model       Date:  2010-11-09       Impact factor: 2.432

3.  Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.

Authors:  Kenneth J Pienta; Natalie McGregor; Robert Axelrod; David E Axelrod
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

Review 4.  Evolutionary medicine: update on the relevance to family practice.

Authors:  Christopher T Naugler
Journal:  Can Fam Physician       Date:  2008-09       Impact factor: 3.275

5.  Molecular imaging in oncology.

Authors:  A S K Dzik-Jurasz
Journal:  Cancer Imaging       Date:  2004-10-21       Impact factor: 3.909

Review 6.  Recent advances in acute myeloid leukemia stem cell biology.

Authors:  Sarah J Horton; Brian J P Huntly
Journal:  Haematologica       Date:  2012-04-17       Impact factor: 9.941

Review 7.  Evolutionary determinants of cancer.

Authors:  Mel Greaves
Journal:  Cancer Discov       Date:  2015-07-20       Impact factor: 39.397

8.  Clonal origin and evolution of a transmissible cancer.

Authors:  Claudio Murgia; Jonathan K Pritchard; Su Yeon Kim; Ariberto Fassati; Robin A Weiss
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

9.  The great opportunity: Evolutionary applications to medicine and public health.

Authors:  Randolph M Nesse; Stephen C Stearns
Journal:  Evol Appl       Date:  2008-02       Impact factor: 5.183

10.  Toward a general evolutionary theory of oncogenesis.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  Evol Appl       Date:  2012-12-05       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.